Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 25th Annual Healthcare Conference
November 01 2016 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the Credit Suisse 25th Annual
Healthcare Conference on Tuesday, Nov. 8, 2016, at 9:30 a.m. MT
(11:30 a.m. ET/4:30 p.m. GMT) from The Phoenician in Scottsdale,
AZ. The presentation may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161101006156/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024